Latest News and Press Releases

SPOKANE, Wash., Dec. 29, 2025 (GLOBE NEWSWIRE) -- In its third and fourth quarters of 2025, the Avista Foundation awarded a combined $336,150 in grants to 76 nonprofit organizations across...

FDA has approved the Wegovy® pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term

TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”), is pleased to announce that it has delivered a notice to exercise its...

ANN ARBOR, Mich., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its proprietary PALM™ nanotechnology,...

WASHINGTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that Dr. Xi Chen, Professor and Andre Meyer Faculty Fellow at the Department of Technology, Operations...

Charleston, SC, Dec. 16, 2025 (GLOBE NEWSWIRE) -- In Lansky’s Gold, a gripping historical adventure by Duane Kennedy Nelson, readers are transported back to 1956 when a lobster boat laden with over...

TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Sintana Energy Inc. (TSX-V: SEI, OTCQX: SEUSF) (“Sintana” or the “Company”) is pleased to provide the following update that on 12 December 2025, Challenger...

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability in the European Union (EU)

TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Sintana Energy Inc. (TSX-V: SEI, OTCQX: SEUSF) (“Sintana” or the “Company”) announces that Challenger and Sintana (TSXV:SEI) are pleased to announce that...

TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Sintana Energy Inc. (TSX-V: SEI, OTCQX: SEUSF) (“Sintana” or the “Company”) announces that on October 9 2025, the board of Sintana (TSXV: SEI) and the...